[-] Show simple item record

dc.contributor.authorKerns, J. Williameng
dc.contributor.authorMabry, Sandieng
dc.date.issued2001-10eng
dc.description.abstractWomen on standard estrogen/progestin hormone replacement therapy (HRT) regimens frequently have irregular bleeding during the first 12 months of treatment. Therefore, those taking HRT should usually be evaluated after 1 year of treatment if bleeding continues. (Grade of recommendation: C, based on case series.) Evaluation of this bleeding should begin with a pelvic examination and Papanicolaou (Pap) test (if not done in the previous 12 months), then transvaginal ultrasound (TVUS), followed by endometrial biopsy or hysteroscopy, if indicated. (Grade: B, based on a systematic review of studies.)eng
dc.identifier.urihttp://hdl.handle.net/10355/2817eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofClinical Inquiries, 2001 (MU)eng
dc.relation.ispartofcollectionUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.subjectendometrial biopsyeng
dc.subjecthormone replacement therapy (HRT)eng
dc.subjectvaginal bleedingeng
dc.subject.lcshMenopause Hormone Therapyeng
dc.subject.lcshHysteroscopyeng
dc.subject.lcshEndometriumeng
dc.subject.lcshBiopsyeng
dc.subject.lcshGynecologyeng
dc.titleWhat is the best diagnostic approach to postmenopausal vaginal bleeding in women taking hormone replacement therapy?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record